Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia

Sonia Christian, MD, Pritesh Patel, MB, CHB, Aysenur Esen, MD, Irum Khan, MBBS, Karen Sweiss, PharmD, Fares Ghanem, MD, Christopher A. Sequeira, MD, Ardaman Shergill, MD, John G. Quigley, MD

Blood (2017) 130 (Supplement 1): 2591.

https://doi.org/10.1182/blood.V130.Suppl_1.2591.2591

Published: 2017

Journal Articles

Acute Kidney Injury before Day 90 Predicts for Both Early and Late Mortality after FluBu4

Karen Sweiss, PharmD, Annie L. Oh, MD, John G. Quigley, MD, Gregory Sampang Calip, PharmD,MPH,PhD, Damiano Rondelli, MD, Pritesh Patel, MB, CHB

Blood (2017) 130 (Supplement 1): 1941.

https://doi.org/10.1182/blood.V130.Suppl_1.1941.1941

Published: 2017

Journal Articles

Similar Survival but Increased Toxicity with a Sequential Versus Concurrent FluBu4 Regimen

Karen Sweiss, PharmD, Annie L. Oh, MD, Gregory Sampang Calip, PharmD,MPH,PhD, John G. Quigley, MD, Damiano Rondelli, MD, Pritesh Patel, MB, CHB

Blood (2017) 130 (Supplement 1): 1942.

https://doi.org/10.1182/blood.V130.Suppl_1.1942.1942

Published: 2017

Journal Articles

Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease

Santosh L. Saraf, MD, Pritesh Patel, MB, CHB, Karen Sweiss, PharmD, Oh Annie, MD, Matthew Koshy, MD, Sally Campbell-lee, MD, Michel Gowhari, DO, Shivi Jain, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Nadim Mahmud, MBBS, PhD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2017) 130 (Supplement 1): 4591.

https://doi.org/10.1182/blood.V130.Suppl_1.4591.4591

Published: 2017

Journal Articles

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

John G. Quigley, MD, Basharath Khan, MD, Nandini Kalakota, MD, Nathan Aardsma, DO, Nadim Mahmud, MBBS, PhD

Blood (2017) 130 (Supplement 1): 5259.

https://doi.org/10.1182/blood.V130.Suppl_1.5259.5259

Published: 2017

Journal Articles

Targeted Depletion of Amino Acids As a Novel Therapy for Acute Leukemia and Other Cancers: Mechanisms and Countermechanisms

Aysenur Esen, MD, Anwar A Khan, PhD, Jason Chan, Nadim Mahmud, MD PhD, John G. Quigley, MD

Blood (2016) 128 (22): 4716.

https://doi.org/10.1182/blood.V128.22.4716.4716

Published: 2016

Journal Articles

A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy

Jennifer Anderson, PharmD, Scott Wirth, PharmD, Pritesh R. Patel, MD, John G. Quigley, MD, Annie L. Oh, MD, Christina Mactal-Haaf, PharmD, Irum Khan, MD, Damiano Rondelli, MD, Karen Sweiss, PharmD

Blood (2016) 128 (22): 2207.

https://doi.org/10.1182/blood.V128.22.2207.2207

Published: 2016

Journal Articles

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Karen Sweiss, PharmD, John G. Quigley, MD, Santosh L. Saraf, MD, Irum Khan, MD, Eileen D. Hacker, PhD APN, AOCN, Nadim Mahmud, MD PhD, David J. Peace, MD, Howard Ozer, MD PhD, Jennifer Windhorst, APN, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2016) 128 (22): 4646.

https://doi.org/10.1182/blood.V128.22.4646.4646

Published: 2016

Journal Articles

Improving Accrual of Adolescents and Young Adults and Underrepresented Minorities with Leukemia to Children's Oncology Group Clinical Trials: A Novel Collaborative Approach to Address Disparities in Leukemia

Nupur Mittal, MD, Mario Martinez, Johnathan Davidson, Paul Kent, MD, Lisa Giordano, MD, Dipti Dighe, MD, Daniel K. Choi, MD MS, Rey Sanchez, John G. Quigley, MD, Rosalind Catchatorian, Cathleen Kiely, APN, Kathleen Breen, APN, Jennifer Misasi, APN, Nitin Sane, Michael Buraglio, Mary Lou Schmidt

Blood (2016) 128 (22): 845.

https://doi.org/10.1182/blood.V128.22.845.845

Published: 2016

Journal Articles

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Santosh L. Saraf, MD, Annie L. Oh, MD, Dolores Mahmud, PhD, Pritesh R. Patel, MB, ChB, Karen Sweiss, PharmD, Matthew Koshy, MD, Sally Campbell-Lee, MD, Michel Gowhari, DO, Johara Hassan, MD, David Peace, MD, John G. Quigley, MD, Irum Khan, MBBS, Robert E. Molokie, MD, Lewis L. Hsu, MD PhD, Nadim Mahmud, MD PhD, Dennis J Levinson, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2014) 124 (21): 2703.

https://doi.org/10.1182/blood.V124.21.2703.2703

Published: 2014

Journal Articles

Transient Activation Of Inflammatory Molecules By Epigenetic Modifiers Likely Plays a Role In Expansion Of Transplantable Human Cord Blood Stem/Progenitor Cells

Nadim Mahmud, MD, PhD, Benjamin Petro, BS, Xinmin Li, PhD, Simona Taioli, MS, Alvin Li, John G. Quigley, MD, Donald Lavelle, Ph.D.

Blood (2013) 122 (21): 1170.

https://doi.org/10.1182/blood.V122.21.1170.1170

Published: 2013

Journal Articles

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Pritesh R. Patel, MB, ChB, Annie L. Oh, MD, Matthew Koshy, MD, Bulent Aydogan, PhD, Nadim Mahmud, MD, PhD, David Peace, MD, John G. Quigley, MD, Santosh L. Saraf, MD, Enzo DeMasi, MD, Ralph R Weichselbaum, MD, Damiano Rondelli, MD

Blood (2013) 122 (21): 3285.

https://doi.org/10.1182/blood.V122.21.3285.3285

Published: 2013

Journal Articles

Evaluation of Genotoxicity of Chromatin Modifying Agents Expanded Hematopoietic Graft in a Non-Human Primate Model.

Simona Taioli, MS, Benjamin Petro, BS, Sujata Gaitonde, MD, John G. Quigley, MD, Valerie Lindgren, PhD, Manuel Borce, MS, Karen Sweiss, PharmD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2012) 120 (21): 2994.

https://doi.org/10.1182/blood.V120.21.2994.2994

Published: 2012

Journal Articles

Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

Annie L. Oh, MD, Pritesh R. Patel, MB, ChB, Santosh Saraf, MD, Karen Sweiss, PharmD, David Peace, MD, John G. Quigley, MD, Nadim Mahmud, MD, PhD, Steven Dudek, MD, Damiano Rondelli, MD

Blood (2012) 120 (21): 4474.

https://doi.org/10.1182/blood.V120.21.4474.4474

Published: 2012

Journal Articles

Role of Ethnicity in Clinical Outcomes of Patients with Ph-Negative Myeloproliferative Neoplasms

Santosh Saraf, MD, Ardaman Shergill, MD, Pritesh R. Patel, MB, ChB, John G. Quigley, MD, David Peace, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2012) 120 (21): 2076.

https://doi.org/10.1182/blood.V120.21.2076.2076

Published: 2012

Journal Articles

Ex Vivo Expansion of Human Mobilized Peripheral Blood Stem Cells Using Epigenetic Modifiers

Santosh Saraf, MD, Hiroto Araki, MD, PhD, Benjamin Petro, BS, Kazumi G Yoshinaga, MS, Simona Taioli, MS, Amer Sidani, MD, John G. Quigley, MD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2011) 118 (21): 1920.

https://doi.org/10.1182/blood.V118.21.1920.1920

Published: 2011

Journal Articles

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Benjamin Petro, BS, Kazumi G Yoshinaga, MS, Dolores Mahmud, PhD, Simona Taioli, MS, Santosh Saraf, MD, Amer Sidani, MD, John G. Quigley, MD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2011) 118 (21): 4016.

https://doi.org/10.1182/blood.V118.21.4016.4016

Published: 2011

Journal Articles

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Santosh Saraf, MD, Pritesh R. Patel, MB, ChB, Howard Ozer, MD, PhD, David Peace, MD, Sangeetha Nimmagadda, MD, John G. Quigley, MD, Damiano Rondelli, MD

Blood (2011) 118 (21): 4213.

https://doi.org/10.1182/blood.V118.21.4213.4213

Published: 2011

Journal Articles

Anopheline Orthologs of the Human Erythroid Heme Exporter, FLVCR, Export Heme: Potential Targets to Inhibit Plasmodium Transmission

Jong J Jeong, PhD, Anwar A Khan, PhD, Michael Lamm, BS, Stefan M Kanzok, PhD, John G. Quigley, MD

Blood (2010) 116 (21): 2.

https://doi.org/10.1182/blood.V116.21.2.2

Published: 2010

Journal Articles

Valproic Acid Results In Maintenance but Not Expansion of Transplantable Hematopoietic Stem Cells From Human Umbilical Cord Blood

Hiroto Araki, MD, PhD, Sudhakar Baluchamy, PhD, Benjamin Petro, Mirza Saqib Baig, PhD, Montha Suhangul, MD, John G. Quigley, MD, Naoyuki Katayama, MD, PhD, Nadim Mahmud, MD, PhD

Blood (2010) 116 (21): 827.

https://doi.org/10.1182/blood.V116.21.827.827

Published: 2010

NARROW

A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia

Acute Kidney Injury before Day 90 Predicts for Both Early and Late Mortality after FluBu4

Similar Survival but Increased Toxicity with a Sequential Versus Concurrent FluBu4 Regimen

Stable Engraftment with Haploidentical Peripheral Blood Stem Cell Transplantation in Adult Patients with Sickle Cell Disease

Chronic Myeloid Leukemia in Chronic Phase As an Adrenal Tumor Masquerading As a Myelolipoma

Targeted Depletion of Amino Acids As a Novel Therapy for Acute Leukemia and Other Cancers: Mechanisms and Countermechanisms

A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy

A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma

Improving Accrual of Adolescents and Young Adults and Underrepresented Minorities with Leukemia to Children's Oncology Group Clinical Trials: A Novel Collaborative Approach to Address Disparities in Leukemia

Alemtuzumab/Low Dose Radiation Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation for Adult Patients with Sickle Cell Disease (SCD)

Transient Activation Of Inflammatory Molecules By Epigenetic Modifiers Likely Plays a Role In Expansion Of Transplantable Human Cord Blood Stem/Progenitor Cells

Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study

Evaluation of Genotoxicity of Chromatin Modifying Agents Expanded Hematopoietic Graft in a Non-Human Primate Model.

Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

Role of Ethnicity in Clinical Outcomes of Patients with Ph-Negative Myeloproliferative Neoplasms

Ex Vivo Expansion of Human Mobilized Peripheral Blood Stem Cells Using Epigenetic Modifiers

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Anopheline Orthologs of the Human Erythroid Heme Exporter, FLVCR, Export Heme: Potential Targets to Inhibit Plasmodium Transmission

Valproic Acid Results In Maintenance but Not Expansion of Transplantable Hematopoietic Stem Cells From Human Umbilical Cord Blood

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only